Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:45:54.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of versions of the study record for the clinical trial involving Pembrolizumab (MK-3475) for non-small cell lung cancer. This change likely reflects a new submission or update to the study documentation or results.
    Difference
    0.3%
    Check dated 2024-05-22T21:33:21.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:36:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.